Unicycive Therapeutics

North America Legal Chronicle. April 2, 2024

Unicycive Therapeutics’ $50 Million Private Placement

By Laura Testa

Sheppard Mullin advised Unicycive Therapeutics in the transaction. Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease, executed its $50...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

North America Legal Chronicle. April 12, 2023

Unicycive Therapeutics’ $130 Million Private Placement

By Martina Bellini

Sheppard Mullin advised Unicycive Therapeutics on the deal. Unicycive Therapeutics, Inc. (Nasdaq: UNCY) (the “Company” or “Unicycive”), a clinical-stage biotechnology company developing therapies for patients with kidney...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

American Tower’s $1.2 Billion Notes Offering

Tex-Tech Industries’ $165 Million Acquisition of Fiber Materials

Outbuild’s $11 Million Series A Financing Round

‘Mercado Crédito XXIX’ Financial Trusts’s US$43 Million Issuance

TuSueldoYa’s Capital Increase

360 Energy Solar’s US$22 Million Green Notes Issuance

Symrise’s Public Offer for Probi

Eleven Ventures’ Investment in Cloud Office

Sixth Street’s Joint Venture with Copley Point

Saudi Egyptian Developers’ EGP4.35 Billion Syndicated Loan

Tamweely’s EGP 5 Billion Securitization Program

TE H2, CIP, and A.P. Moller Capital’s Developmente Of Large-Scale Green Hydrogen Project In Morocco

Taaleem Holdings’ Acquisition of Lycée Libanais Francophone Privé Meydan School

Commercial Bank of Dubai’s US$500 Million Bond Issuance

Medianova’s Investment Round

Vee Healthtek’s Investment Round

Afcons Infrastructure’s $645 Million IPO

Godavari Biorefineries Limited’s Initial Public Offering

King & Spalding Continues Antitrust Growth with Addition of Partner Olivier N. Antoine in New York

Real Estate Partner Brian Crist Joins Barnes & Thornburg

Paul, Weiss Welcomes Two Leading Life Science & Technology Litigators in New York

The Diarra Ruling On The Transfer Of Players Within The EU And The FIFA Regulation On The Status And Transfer Of Players

The Distinctive Character Of The ‘Vespa’ Is No Longer In Question

Cultural Heritage Sites With Restrictions On Intended Use: The Council of State Acknowledges That This Power Lies In the Hands Of The Ministry Of Culture

King & Spalding Continues Antitrust Growth with Addition of Partner Olivier N. Antoine in New York

Real Estate Partner Brian Crist Joins Barnes & Thornburg

Paul, Weiss Welcomes Two Leading Life Science & Technology Litigators in New York

Unicycive Therapeutics’ $50 Million Private Placement

Standard 1 Year Membership Required

Unicycive Therapeutics’ $130 Million Private Placement

Standard 1 Year Membership Required